Company
Merck & Co Inc MRK
Tracked across 13 disclosed holders on Protégé.
8 tracked investors, latest 13F quarter ending 30 Jun 2026 · 4 members of Congress · 1 executive · latest filing 7 Oct 2026
Held by these investors
| Investor | Weight in portfolio | Value (13F) | Quarter ending |
|---|---|---|---|
| Antipodes Partners | 2.6% | $141.0M | 2026-06-30 |
| Samlyn Capital | 1.2% | $72.7M | 2026-06-30 |
| Alyeska Investment Group | 0.8% | $318.8M | 2026-06-30 |
| Voleon Group | 0.7% | $38.0M | 2026-06-30 |
| Woodline Partners | 0.4% | $144.5M | 2026-06-30 |
| Adage Capital Management | 0.4% | $260.9M | 2026-06-30 |
| Cliff Asness | 0.4% | $1.0B | 2026-06-30 |
| Farallon Capital Management | 0.2% | $25.6M | 2026-06-30 |
Members of Congress who disclosed trades
| Politician | Disclosed activity | Est. net |
|---|---|---|
| Maria Elvira Salazar | 2 buys / 1 sell | $57K |
| Josh Gottheimer | 1 buy / 0 sells | $8K |
| Jared Moskowitz | 1 buy / 0 sells | $8K |
| Julie Johnson | 0 buys / 1 sell | -$8K |
Company executives who disclosed trades
| Executive | Disclosed activity | Net |
|---|---|---|
| Robert Davis | 0 buys / 1 sell | -$5.6M |
Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.